Biochemistry
| Full details for "Infliximab/Inflectra". | |
|---|---|
Name |
Infliximab/Inflectra |
Alternative name/Profile |
Inflectra (Biosimilar Drug of Infliximab) Infliximab IFX IFN |
Department |
Biochemistry |
Investigation |
IFX/INF used in treatment of Inflammatory Bowel Disease (Crohn’s Disease and Ulcerative Colitis) when there is an inadequate response to conventional therapy Therapeutic drug monitoring of IFX/INF used in the management of clinical response to therapy |
Specimen type |
Serum |
Sample type |
|
Sample container & volume |
5 ml - Red Tube |
Frequency of analysis |
Twice monthly |
Turnaround time |
10 working days |
Availability |
Currently St. James’s Hospital only |
Notes |
External users subject to service level agreement. Contact laboratory for further information Trough sample required taken immediately before next infusion Fasting not required Samples with gross haemolysis, lipaemia or icterus not suitable for assay Stability: Serum stable for up to 7 days at room temperature. For longer store at minimum -20oC |
Related links |
|
Reference range |
<3.0 µg/ml: sub-therapeutic 3.0-7.0 µg/ml: therapeutic >7.0 µg/ml: possible toxicity (adjust dosage) No age or gender associated differences No difference between children and adults |
Last updated |
Fri, 16 Aug 2024 10:50:42 IST |